EUVIMEDEUVIMED entdecken
Crossref

Chlorambucil-Loaded Nanomicelles against Hepatocellular Carcinoma

Wenhua Li, Xiaoyan Xu, Xiujuan Li, Ligong Liu, Xueting Song, Zhijie Li, Xinran Wang, Du Wu, Dapeng Zhang, Mingming Lian

ACS Applied Nano Materials · 14.08.2026 · 9 (32) · 15453-15470

DOI: 10.1021/acsanm.6c02549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Nano Materials, online erschienen am 04.08.2026. Verfasst von Wenhua Li und 9 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Natural Science Foundation of Heilongjiang Province, Postgraduate Research & Practice Innovation Program of Harbin Medical University, Fundamental Research Funds for the Provincial Universities.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For hepatocellular carcinoma (HCC) therapy, an NQO1-responsive chlorambucil-loaded nanomicelle (CLB-AZO-mPEG5) was designed and synthesized to overcome the poor water solubility of chlorambucil and to explore its mechanism against HCC. CLB-AZO-mPEG5 was constructed by conjugating hydrophobic chlorambucil with hydrophilic monomethoxypolyethylene glycol via an azobenzene linker, enabling specific drug release upon cleavage by NQO1, which is highly expressed in the tumor microenvironment. CLB-AZO-mPEG5 nanomicelles exhibited a filamentous nanostructure with good dispersibility, stability, and biosafety. Cellular assays demonstrated that CLB-AZO-mPEG5 significantly inhibited the proliferation of HepG2 cells, and this effect was markedly attenuated upon NQO1 knockdown, indicating that its antitumor activity is NQO1-dependent. In a HepG2-RAW264.7 coculture system, CLB-AZO-mPEG5 significantly upregulated M1 macrophage markers (CD86, iNOS) and pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), while downregulating M2 markers (CD206, Arg-1) and anti-inflammatory cytokines (IL-10, TGF-β, Arg-1). In a tumor-bearing mouse model, CLB-AZO-mPEG5 significantly reduced tumor volume and inhibited tumor proliferation, showing superior antitumor efficacy compared to the nonresponsive CLB-mPEG5 group. Mechanistic studies using transcriptome sequencing and qPCR confirmed that CLB-AZO-mPEG5 modulates the tryptophan-AhR-Cyp1 axis-related genes, thereby modulating macrophage phenotype in a coculture system and potentially influencing the tumor immune microenvironment. Collectively, CLB-AZO-mPEG5 exerts anti-HCC effects through NQO1-responsive release of chlorambucil, regulation of the tryptophan-AhR-Cyp1 axis, and induction of M1 macrophage polarization, representing a promising targeted nanodelivery system. These results demonstrate that CLB-AZO-mPEG5 nanomicelles represent a promising nanomedicine platform for targeted HCC chemotherapy.

Förderung

  • Natural Science Foundation of Heilongjiang Province
  • Postgraduate Research & Practice Innovation Program of Harbin Medical University
  • Fundamental Research Funds for the Provincial Universities

Zitieren

APA

Li, W., Xu, X., Li, X., Liu, L., Song, X., Li, Z., Wang, X., Wu, D., Zhang, D., & Lian, M. (2026). Chlorambucil-Loaded Nanomicelles against Hepatocellular Carcinoma. ACS Applied Nano Materials, 9(32), 15453-15470. https://doi.org/10.1021/acsanm.6c02549

Vancouver

Li W, Xu X, Li X, Liu L, Song X, Li Z, et al. Chlorambucil-Loaded Nanomicelles against Hepatocellular Carcinoma. ACS Applied Nano Materials. 2026;9(32):15453-15470. doi:10.1021/acsanm.6c02549

BibTeX
@article{Li2026,
  author = {Li, Wenhua and Xu, Xiaoyan and Li, Xiujuan and Liu, Ligong and Song, Xueting and Li, Zhijie and Wang, Xinran and Wu, Du and Zhang, Dapeng and Lian, Mingming},
  title = {Chlorambucil-Loaded Nanomicelles against Hepatocellular Carcinoma},
  journal = {ACS Applied Nano Materials},
  year = {2026},
  volume = {9},
  number = {32},
  pages = {15453--15470},
  doi = {10.1021/acsanm.6c02549}
}
Kostenlos starten →